AC
Adicet Bio, Inc.
ACET · NASDAQ
$9.15 -1.77% (-$0.17)
1M +2.81%
Market Cap $85.5M
P/E Ratio -
Div. Yield -
ROE 74.90%
Bulios Fair Price
$6.29
31.2% downside
Current Price
$9.15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ACET is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.71x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 18.34%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 78.09%
ROE 74.90%
Asset turnover 0.00x
Debt
69 /100
Low Debt/Equity 0.11x
Current ratio 6.71x
Int. coverage -1,219.14x
Stability
10 /100
Unstable Beta 1.59x
EPS volatility 80.28%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ACET
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chen Schor
Employees
102
Headquarters
Boston
Upcoming events
04 NOV
Earnings
Upcoming earnings report